These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 27027633)
1. Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa. Hamza M; Idris MA; Maiyaki MB; Lamorde M; Chippaux JP; Warrell DA; Kuznik A; Habib AG PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004568. PubMed ID: 27027633 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria. Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252 [TBL] [Abstract][Full Text] [Related]
3. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa. Habib AG; Warrell DA Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853 [TBL] [Abstract][Full Text] [Related]
5. The snakebite problem and antivenom crisis from a health-economic perspective. Habib AG; Brown NI Toxicon; 2018 Aug; 150():115-123. PubMed ID: 29782952 [TBL] [Abstract][Full Text] [Related]
6. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom. Casewell NR; Cook DA; Wagstaff SC; Nasidi A; Durfa N; Wüster W; Harrison RA PLoS Negl Trop Dis; 2010 Oct; 4(10):e851. PubMed ID: 21049058 [TBL] [Abstract][Full Text] [Related]
7. A prospective observational phase IV study on effectiveness of animal derived polyclonal antibody antivenoms against West African carpet viper (Echis romani) induced coagulopathy and mortality. Dajel TB; Abubakar SB; Dan-Amarya NM; Azi NA; Mu'azu S; Hamza M; Iliyasu G; Gwarzo MY; Habib AG Toxicon; 2023 Aug; 232():107211. PubMed ID: 37393958 [TBL] [Abstract][Full Text] [Related]
8. Successful Management of Two Patients with Intracranial Hemorrhage due to Carpet Viper (Echis ocellatus) Envenomation in a Limited-Resource Environment. Benjamin JM; Chippaux JP; Tamou-Sambo B; Akpakpa OC; Massougbodji A Wilderness Environ Med; 2019 Sep; 30(3):295-301. PubMed ID: 31229367 [TBL] [Abstract][Full Text] [Related]
9. Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial. Potet J; Smith J; McIver L PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007551. PubMed ID: 31233536 [TBL] [Abstract][Full Text] [Related]
10. Potential economic and clinical implications of improving access to snake antivenom in five ASEAN countries: A cost-effectiveness analysis. Patikorn C; Ismail AK; Zainal Abidin SA; Othman I; Chaiyakunapruk N; Taychakhoonavudh S PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010915. PubMed ID: 36383562 [TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics. Calvete JJ; Arias AS; Rodríguez Y; Quesada-Bernat S; Sánchez LV; Chippaux JP; Pla D; Gutiérrez JM Toxicon; 2016 Sep; 119():280-8. PubMed ID: 27377229 [TBL] [Abstract][Full Text] [Related]
12. Experimental assessment of a new, low-cost antivenom for treatment of carpet viper (Echis ocellatus) envenoming. Laing GD; Lee L; Smith DC; Landon J; Theakston RD Toxicon; 1995 Mar; 33(3):307-13. PubMed ID: 7638870 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria. Sánchez LV; Pla D; Herrera M; Chippaux JP; Calvete JJ; Gutiérrez JM Toxicon; 2015 Nov; 106():97-107. PubMed ID: 26415904 [TBL] [Abstract][Full Text] [Related]
14. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209 [TBL] [Abstract][Full Text] [Related]
15. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease? Laustsen AH; Johansen KH; Engmark M; Andersen MR PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193 [TBL] [Abstract][Full Text] [Related]
16. Scaling up antivenom for snakebite envenoming in the Brazilian Amazon: a cost-effectiveness analysis. Zimmerman A; Monteiro W; Nickenig Vissoci JR; Smith ER; Rocha T; Sachett J; Wen FH; Staton C; Gerardo CJ; Ogbuoji O Lancet Reg Health Am; 2024 Jan; 29():100651. PubMed ID: 38124996 [TBL] [Abstract][Full Text] [Related]
17. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa. Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Calvete JJ; Theakston RD; Warrell DA; Gutiérrez JM Toxicon; 2010; 55(2-3):369-74. PubMed ID: 19699756 [TBL] [Abstract][Full Text] [Related]
18. Performance of the 20 minutes Whole Blood Clotting Test in detection, monitoring and antivenom therapy of West African Carpet viper (Echis romani) envenoming in resource constrained settings in Nigeria. Hamza M; Dajel TB; Abubakar SB; Hamza AS; Abdullahi HL; Iliyasu G; Habib AG Toxicon; 2023 Mar; 224():107025. PubMed ID: 36640811 [TBL] [Abstract][Full Text] [Related]
19. Effect of distance and delay in access to care on outcome of snakebite in rural north-eastern Nigeria. Iliyasu G; Tiamiyu AB; Daiyab FM; Tambuwal SH; Habib ZG; Habib AG Rural Remote Health; 2015; 15(4):3496. PubMed ID: 26590373 [TBL] [Abstract][Full Text] [Related]
20. Health and economic burden estimates of snakebite management upon health facilities in three regions of southern Burkina Faso. Ahmed S; Koudou GB; Bagot M; Drabo F; Bougma WR; Pulford C; Bockarie M; Harrison RA PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009464. PubMed ID: 34153048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]